P. Persons

The synthesis and SAR of new 4-(N-alkyl-N-phenyl)amino-6,7-dimethoxyquinazolines and 4-(N-alkyl-N-phenyl)aminopyrazolo[3,4-d]pyrimidines, inhibitors of CSF-1R tyrosine kinase activity

D. Cheney, A. Zilberstein, M. Myers, 1997 .

Stimulation of presynaptic dopamine autoreceptors by 4-(2-di-n-propylaminoethyl) indole (DPAI).

D. E. Nichols, P. Persons, J. Clemens, 1984, Life sciences.

The antiproliferative effects of tyrosine kinase inhibitors tyrphostins on a human squamous cell carcinoma in vitro and in nude mice.

M. M. Alsina, A. Zilberstein, T. Yoneda, 1991, Cancer research.

Kinetic analysis of the inhibition of the epidermal growth factor receptor tyrosine kinase by Lavendustin-A and its analogue.

A. Zilberstein, P. Persons, A. Levitzki, 1991, The Journal of biological chemistry.

Restenosis following angioplasty in the swine coronary artery is inhibited by an orally active PDGF-receptor tyrosine kinase inhibitor, RPR101511A.

C. Dunwiddie, A. Spada, P. Persons, 1999, Circulation.

A novel enantioselective cyclization of a chiral epoxide to a benzofuran system

P. Persons, O. Ko, J. Cassady, 1987 .